Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

NCT05180773 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Peripartum Cardiomyopathy, Postpartum

Interventions

DRUG: Bromocriptine
DRUG: Placebo
DRUG: Guideline Directed Medical Therapy for Heart Failure (GDMT)
DRUG: Rivaroxaban
DRUG: Second Placebo

Sponsor

Dennis M. McNamara, MD, MS

Collaborators

[object Object]